Nubeqa (darolutamide)
Australian Public Assessment Report
Device/Product Name
Nubeqa
Active ingredients
Darolutamide
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-00878-1-4
Submission Type
Extension of indications
Decision
Approved